6901 - 6925 of 8100 Results
Title
Year
-
OPENTitle: Targeting β-arrestin2 in the treatment ofl-DOPA–induced dyskinesia in Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 112Issue #: 19Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1502740112Best OA location URL: https://www.pnas.org/content/pnas/112/19/E2517.full.pdfCitation Count: 96
-
OPENTitle: Identification of rare protein disulfide isomerase gene variants in amyotrophic lateral sclerosis patientsJournal Name: GenePublisher: Elsevier BVVol: 566Issue #: 2Start Page: 158End Page: 165Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.gene.2015.04.035Best OA location URL: https://europepmc.org/articles/pmc5553116?pdf=renderCitation Count: 70
-
RESTRICTEDTitle: Impact of Parkinson's disease risk loci on age at onsetJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 6Start Page: 847End Page: 850Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26237Citation Count: 49
-
OPENTitle: Differential involvement of Ras‐GRF1 and Ras‐GRF2 in L‐DOPA‐induced dyskinesiaJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 2Issue #: 6Start Page: 662End Page: 678Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.202Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.202Citation Count: 20
-
OPENTitle: Common genetic variant association with altered HLA expression, synergy with pyrethroid exposure, and risk for Parkinson’s disease: an observational and case–control studyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 1Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/npjparkd.2015.2Best OA location URL: https://www.nature.com/articles/npjparkd20152.pdfCitation Count: 119
-
OPENTitle: Structural Characterization of LRRK2 InhibitorsJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 58Issue #: 9Start Page: 3751End Page: 3756Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jm5018779Best OA location URL: https://pure.rug.nl/ws/files/85554165/Structural_Characterization_of_LRRK2_Inhibitors.pdfCitation Count: 37
-
OPENTitle: Classification of pallidal oscillations with increasing parkinsonian severityJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 114Issue #: 1Start Page: 209End Page: 218Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1152/jn.00840.2014Best OA location URL: https://europepmc.org/articles/pmc4507953Citation Count: 21
-
RESTRICTEDTitle: LRRK2 mutations and neurotoxicant susceptibilityJournal Name: Experimental Biology and MedicinePublisher: Frontiers Media SAVol: 240Issue #: 6Start Page: 752End Page: 759Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/1535370215579162Best OA location URL: https://europepmc.org/articles/pmc4935210?pdf=renderCitation Count: 28
- Therapeutic deep brain stimulation reduces cortical phase-amplitude coupling in Parkinson's disease2015OPENTitle: Therapeutic deep brain stimulation reduces cortical phase-amplitude coupling in Parkinson's diseaseJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 18Issue #: 5Start Page: 779End Page: 786Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nn.3997Best OA location URL: https://europepmc.org/articles/pmc4414895?pdf=renderCitation Count: 575
-
RESTRICTEDTitle: Ser129 phosphorylation of endogenous α-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and functionJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 78Issue #:Start Page: 100End Page: 114Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2015.03.008Citation Count: 23
-
OPENTitle: Increased 14-3-3 phosphorylation observed in Parkinson's disease reduces neuroprotective potential of 14-3-3 proteinsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 79Issue #:Start Page: 1End Page: 13Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2015.02.032Best OA location URL: https://europepmc.org/articles/pmc4458424?pdf=renderCitation Count: 40
-
RESTRICTEDTitle: Minimal change multiple system atrophy: An aggressive variant?Journal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 7Start Page: 960End Page: 967Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26220Citation Count: 48
-
OPENTitle: Onset of Mild Cognitive Impairment in Parkinson DiseaseJournal Name: Alzheimer Disease & Associated DisordersPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 30Issue #: 2Start Page: 127End Page: 133Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wad.0000000000000088Best OA location URL: https://epublications.marquette.edu/cgi/viewcontent.cgi?article=1530&context=nursing_facCitation Count: 30
-
OPENTitle: Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective, and Brain Penetrant LRRK2 InhibitorJournal Name: ACS Medicinal Chemistry LettersPublisher: American Chemical Society (ACS)Vol: 6Issue #: 5Start Page: 584End Page: 589Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsmedchemlett.5b00064Best OA location URL: https://europepmc.org/articles/pmc4434483?pdf=renderCitation Count: 49
- Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials2015RESTRICTEDTitle: Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trialsJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 84Issue #: 14Start Page: 1488End Page: 1494Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000001451Best OA location URL: https://europepmc.org/articles/pmc4395889?pdf=renderCitation Count: 49
-
OPENTitle: Rationally Designed MicroRNA-Based Genetic Classifiers Target Specific Neurons in the BrainJournal Name: ACS Synthetic BiologyPublisher: American Chemical Society (ACS)Vol: 4Issue #: 7Start Page: 788End Page: 795Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acssynbio.5b00040Best OA location URL: https://europepmc.org/articles/pmc4547530?pdf=renderCitation Count: 27
-
OPENTitle: Conventional 3T brain MRI and diffusion tensor imaging in the diagnostic workup of early stage parkinsonismJournal Name: NeuroradiologyPublisher: Springer Science and Business Media LLCVol: 57Issue #: 7Start Page: 655End Page: 669Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00234-015-1515-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00234-015-1515-7.pdfCitation Count: 41
-
OPENTitle: Performance of the CogState computerized battery in the Mayo Clinic Study on AgingJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 11Issue #: 11Start Page: 1367End Page: 1376Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2015.01.008Best OA location URL: https://europepmc.org/articles/pmc4595161?pdf=renderCitation Count: 106
- Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice2015OPENTitle: Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in miceJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 78Issue #:Start Page: 172End Page: 195Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2015.02.031Best OA location URL: https://europepmc.org/articles/pmc4526103?pdf=renderCitation Count: 228
-
RESTRICTEDTitle: Activation of the E3 ubiquitin ligase ParkinJournal Name: Biochemical Society TransactionsPublisher: Portland Press Ltd.Vol: 43Issue #: 2Start Page: 269End Page: 274Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1042/bst20140321Best OA location URL: https://europepmc.org/articles/pmc4859148?pdf=renderCitation Count: 45
-
OPENTitle: Serum- and Glucocorticoid-Inducible Kinase 1 Confers Protection in Cell-Based and in In Vivo Neurotoxin Models via the c-Jun N-Terminal Kinase Signaling PathwayJournal Name: Molecular and Cellular BiologyPublisher: Informa UK LimitedVol: 35Issue #: 11Start Page: 1992End Page: 2006Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1128/mcb.01510-14Best OA location URL: https://mcb.asm.org/content/mcb/35/11/1992.full.pdfCitation Count: 21
- Morphological alterations in the caudate, putamen, pallidum, and thalamus in Parkinson's disease2015OPENTitle: Morphological alterations in the caudate, putamen, pallidum, and thalamus in Parkinson's diseaseJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2015.00101Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2015.00101/pdfCitation Count: 63
- α-Synuclein, a chemoattractant, directs microglial migration via H2O2-dependent Lyn phosphorylation2015OPENTitle: α-Synuclein, a chemoattractant, directs microglial migration via H2O2-dependent Lyn phosphorylationJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 112Issue #: 15Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1417883112Best OA location URL: https://www.pnas.org/content/pnas/112/15/E1926.full.pdfCitation Count: 139
-
OPENTitle: Dual κ‐agonist/μ‐antagonist opioid receptor modulation reduces levodopa‐induced dyskinesia and corrects dysregulated striatal changes in the nonhuman primate model of Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 77Issue #: 6Start Page: 930End Page: 941Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.24375Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.24375Citation Count: 49
-
OPENTitle: ER proteostasis disturbances in Parkinson's disease: novel insightsJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 7Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2015.00039Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2015.00039/pdfCitation Count: 31